NIH-funded research R21 grant

Understanding how DNA damage affects inflammation in cells

Official title: NF-KB regulation by the DNA damage response

Funded at University of California-Irvine · NIH-11056607 · Data updated 2026-11-12

This study is looking at how a protein called NF-κB, which helps control inflammation, reacts when our DNA gets damaged by things in our environment, and it’s for anyone interested in understanding how our body's immune system responds to such damage.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of California-Irvine
NIH-funded
Lab location1 site (Irvine, United States)
Project startJanuary 9, 2025
Project endJanuary 8, 2027
Funding year2025
Award (this year)$431,750
NIH project number1R21ES036190-01A1
Project IDNIH-11056607 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals experiencing age-related diseases or conditions associated with DNA damage.

Less likely to help

Patients with conditions unrelated to DNA damage or inflammation may not benefit from this research.

What this research studies

This research investigates the role of NF-κB, a key protein involved in inflammation, in response to DNA damage caused by environmental stress. It focuses on how DNA damage in the nucleus triggers NF-κB activation in the cytoplasm through a signaling pathway regulated by the ATM kinase. The study aims to uncover additional pathways that may activate NF-κB when DNA damage occurs, especially when traditional gene expression processes are blocked. By exploring these mechanisms, the research seeks to enhance our understanding of the innate immune response in the context of DNA damage.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for enhancing the immune response in patients with age-related diseases linked to DNA damage.

How similar studies have gone: Previous research has shown promising results in understanding NF-κB activation pathways, but this specific approach is novel and aims to fill existing knowledge gaps.

Where this research is happening

  • University of California-Irvine
    Irvine, United States
    Active

Researchers

  • Principal investigator: Buisson, Remi — University of California-Irvine
  • Study coordinator: Buisson, Remi

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.